Germany, France, the Netherlands and Italy Wednesday announced the formation of a vaccine alliance aimed at ensuring that a possible future coronavirus vaccine is available and affordable for Europeans.
The four countries have come together under the “Inclusive Vaccine Alliance,” which will look to make sure that Europe not only gets a vaccine at a good price from pharmaceutical companies, but that European production capabilities are prioritized.
Click Here: Cheap France Rugby Jersey
In a statement, the Dutch health ministry says the alliance intends to work with the European Commission and is already in talks with various pharmaceutical companies. It is also offering other EU member countries the opportunity to take part in any initiatives arising from the collaboration.
In addition, Deputy Prime Minister and Health Minister Hugo de Jonge said in a letter announcing the initiative that the alliance is focusing on the “stimulation of vaccine production in European facilities.”
While the aim is to secure access to a vaccine for Europe, de Jonge said the alliance would seek ways to use the available capacity to secure access for more vulnerable countries such as those in Africa.
Today’s announcement comes as countries around the globe seek to shore up their manufacturing capacity and secure preorders of potential future vaccines with pharmaceutical companies.
This article is part of POLITICO’s premium policy service: Pro Health Care. From drug pricing, EMA, vaccines, pharma and more, our specialized journalists keep you on top of the topics driving the health care policy agenda. Email firstname.lastname@example.org for a complimentary trial.